Catalyst Pharma to Be Acquired by Angelini Pharma in $4.1 Billion Deal
The move marks Italy's Angelini Pharma's entry into the U.S. market.
Open original sourceLoading market dashboard
The move marks Italy's Angelini Pharma's entry into the U.S. market.
Open original source